Recently added articles from Gene Therapy Weekly:
Scientists at Nagoya City University publish new data on angiogenesis.
Dec 24, 2009 ... According to recent research published in the journal Molecular and Cellular Biochemistry, "Phosphoinositide 3-kinase (PI3K) pathway exerts its effects through Akt, its downstream target molecule, and thereby regulates various cell functions including cell proliferation, cell ...
Researchers from Astellas Pharma, Inc. detail findings in astellas pharma inc.(Report)
Dec 24, 2009 ... According to a study from Tsukuba, Japan, "Recently, we discovered that transient receptor potential ankyrin1 channel (TRPA1) is highly expressed in human and rat enterochromaffin (EC) cells, and those TRPA1 agonists such as allyl isothiocyanates (AITC) and cinnamaldehyde (CA) enhance the ...
New head and neck cancer study findings have been reported by scientists at University of Pittsburgh.
Dec 24, 2009 ... According to recent research from the United States, "Tumor necrosis factor a converting enzyme (TACE) is a sheddase overexpressed in cancers that generates cancer cell growth and survival factors, and is implicated in carcinogenesis and tumor growth. This indicates that TACE could be a ...
Research from B.W. Peng and co-researchers in the area of hemophilia described.
Dec 24, 2009 ... "One major obstacle in gene therapy is the generation of immune responses directed against transgene product. Five consecutive anti-CD3 treatments concomitant with factor VIII (FVIII) plasmid injection prevented the formation of inhibitory antibodies against FVIII and achieved persistent, ...
Research in the area of hepatitis B virus reported from Y. Fan and colleagues.
Dec 24, 2009 ... According to recent research from Shanghai, People's Republic of China, "Hepatitis B virus (HBV) is a noncytopathic DNA virus and is the pathogen of acute and chronic hepatitis. Interferon and nucleotide analogues such as lamivudine and adefovir are the current treatment strategies of HBV ...